Back to search

Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.

Data up to Jan 2025

Published2001
Citations135
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...